| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.63B | +4.8% |
| Gross Profit | $8.25B | +0.5% |
| R&D Expense | $1.26B | -3.9% |
| SG&A Expense | $4.22B | -1.0% |
| Operating Income | $2.76B | +5.3% |
| Interest Expense | $440.0M | -12.7% |
| Pre-tax Income | $2.77B | +7.2% |
| Income Tax | $614.0M | +15.6% |
| Net Income | $2.08B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.49B | +56.3% |
| Accounts Receivable | $3.96B | +10.9% |
| Inventory | $2.23B | +15.2% |
| Current Assets | $12.50B | +26.3% |
| Total Assets | $36.91B | +11.5% |
| Current Liabilities | $9.11B | -4.7% |
| Long-term Debt | $10.00B | +11.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | -$1.05B | -14.6% |
| Financing Cash Flow | $617.0M | +207.7% |
| +4.6% |
| EPS (Basic) | $4.56 | +4.3% |
| EPS (Diluted) | $4.55 | +4.8% |
| Total Liabilities |
| $26.31B |
| +7.7% |
| Stockholders' Equity | $10.38B | +22.9% |